| Product Name | MF | CAS | Details |
|---|
| mPEG5-SH | C11H24O5S | 524030-00-0 | Details |
| Fmoc-AEEAc-AEEAc-OH | C27H34N2O9 | 560088-89-3 | Details |
| 1,9-Diaminononane | C9H22N2 | 646-24-2 | Details |
| 3-[(Propan-2-yl)amino]benzoic acid | C10H13NO2 | 923112-64-5 | Details |
| (1-Benzyl-4-methylpiperazin-2-yl)methanol | 91904-52-8 | Details |
| Sanggenol A | C25H28O6 | 174423-30-4 | Details |
| N-[3-(1H-Indol-4-yl)-5-(2-methoxypyridine-4-carbonyl)phenyl]methanesulfonamide | C22H19N3O4S | 915412-67-8 | Details |
| 2-(4-Methylphenyl)-2-(pyrrolidin-1-yl)ethan-1-amine | C13H20N2 | 889940-06-1 | Details |
| SR-4995 | C19H21N3O2S | 891509-95-8 | Details |
| 1-Cyclohexyl-2,2-difluoroethan-1-ol | C8H14F2O | 153801-10-6 | Details |
| GABARAP Blocking Peptide | Details |
| Anti ACTH (21-39) (Rat) Serum | Details |
| 2-(5-Methyl-1,2-oxazol-3-yl)acetic acid | C6H7NO3 | 57612-87-0 | Details |
| 5-Bromoisatoic anhydride | C8H4BrNO3 | 4692-98-2 | Details |
| 3,6-Difluoro-2-methoxybenzene-1-sulfonyl chloride | C7H5ClF2O3S | 1162257-28-4 | Details |
| 6-(5-Bromothiophen-2-yl)pyridazin-3-amine | C8H6BrN3S | 1226154-37-5 | Details |
| Methyl 4,6-dichloro-4,6-dideoxy-a-D-glucopyranoside | C7H12Cl2O4 | Details |
| 4-Ethoxybenzenesulfonamide | C8H11NO3S | 1132-19-0 | Details |
| 2,2-Dimethyl-N-[(piperidin-3-yl)methyl]propanamide | C11H22N2O | 1016493-38-1 | Details |
| 7-Chloro-5-methylpyrazolo[1,5-a]pyrimidine-3-carbonitrile | C8H5ClN4 | 138904-34-4 | Details |
| 5-Phenyl-5H-pyrido[3,2-b]indole | C17H12N2 | 1541200-53-6 | Details |
| 3-(1,2,4-Oxadiazol-3-yl)morpholine hydrochloride | C6H10ClN3O2 | 1423805-98-4 | Details |
| 7-Hydroxyheptanoic acid | C7H14O3 | 3710-42-7 | Details |
| (S,R,S)-AHPC-C2-NH2 dihydrochloride | C25H36ClN5O4S | 2341796-73-2 | Details |
| 3,5,7-Trimethyladamantane-1-carboxylic acid | C14H22O2 | 15291-66-4 | Details |
| A-674563 | C22H22N4O | 552325-73-2 | Details |
| 2-(2-Methyl-1H-imidazol-1-yl)pyridine-4-carboxylic acid hydrochloride | C10H10ClN3O2 | 1354957-84-8 | Details |
| NQO1 Blocking Peptide | Details |
| AAV2 antibody | Details |
| Propan-2-yl (2R)-pyrrolidine-2-carboxylate hydrochloride | C8H16ClNO2 | 343962-74-3 | Details |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | C18H18N4O4 | 95261-09-9 | Details |
| PPP1R3A antibody | Details |
| 1-({[(9H-Fluoren-9-yl)methoxy]carbonyl}(methyl)amino)cyclopropane-1-carboxylic acid | C20H19NO4 | 1702888-95-6 | Details |
| CHRNA6 protein (His tag) | Details |
| Levomefolic acid | C20H25N7O6 | 31690-09-2 | Details |
| 2,10,12-triaza-9-(6-chloro-2-fluorophenyl)-5,5-dimethyltricyclo[9.4.0.0<,3,8>,]pentadeca-1(15),3(8),11(12),13-tetraen-7-one | C20H19ClFN3O | 1022505-60-7 | Details |
| (S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol | C13H20N2O2 | 99291-25-5 | Details |
| 1-Hydroxypyrene-d9 | C16HD9O | 132603-37-3 | Details |
| Methyl 4,5-dihydro-1,2-oxazole-5-carboxylate | C5H7NO3 | 15055-75-1 | Details |
| Connexin 43 antibody (Ser265) | Details |
| 1-(Pentamethylbenzenesulfonyl)piperazine | C15H24N2O2S | 900641-37-4 | Details |
| 1-Butylpiperidin-4-amine | C9H20N2 | 50534-21-9 | Details |
| 2-Hydroxycyclopentan-1-one | C5H8O2 | 473-84-7 | Details |
| (2R,3R)-2-Aminobutane-1,3-diol hydrochloride | C4H12ClNO2 | 79474-65-0 | Details |
| 1-Benzyl-decahydro-1,6-naphthyridine | C15H22N2 | 1394040-33-5 | Details |
| UBD protein (His tag) | Details |
| Nor cholic acid | C23H38O5 | 60696-62-0 | Details |
| N-Methyl-4-(1,3-thiazol-2-yl)aniline | C10H10N2S | 1339094-23-3 | Details |
| N-(4-Aminophenyl)acetamide | C8H10N2O | 122-80-5 | Details |
| (2S,5S)-Bishydroxymethyl-(3R,4R)-bishydroxypyrrolidine | C6H13NO4 | 105015-44-9 | Details |
| 4-Amino-2-fluoro-5-methyl-benzoic acid methyl ester | C9H10FNO2 | 1427398-87-5 | Details |
| 4-?Hydroxy-?2,?6-?diphenyl-?4H-?1,?4-?oxaphosphorin 4-?oxide | C16H13O3P | 56153-45-8 | Details |
| Oxysophocarpine | C15H22N2O2 | 26904-64-3 | Details |
| Arg-Gly-Asp TFA salt | C14H23F3N6O8 | 2378808-45-6 | Details |
| 2-(5-Methyl-1H-pyrazol-1-yl)propanohydrazide | C7H12N4O | 1005614-37-8 | Details |
| SCAMP3 antibody (biotin) | Details |
| 1-Benzyl-5-hydroxymethyl-1H-imidazole | C11H12N2O | 80304-50-3 | Details |
| (2E)-3-[2-(4-Methoxyphenyl)-1,3-thiazol-4-yl]prop-2-enoic acid | C13H11NO3S | 874623-16-2 | Details |
| H-SRYWAIRTR-OH | Details |
| Ly49A/D antibody (PE) | Details |
| RELM gamma protein | Details |
| 3-(1H-Pyrazol-5-yl)piperidine | C8H13N3 | 774479-26-4 | Details |
| Calmodulin antibody (biotin) | Details |
| ATP5B antibody | Details |
| PHLDA1 Blocking Peptide | Details |
| (S)-Beta-methyl-gamma-butyrolactone | C5H8O2 | 64190-48-3 | Details |
| N-(3,4-Dimethylphenyl)-2-oxo-2H-chromene-3-carboxamide | C18H15NO3 | 304887-43-2 | Details |
| 1-[(4-Chlorophenyl)methyl]-3-methyl-1H-thieno[2,3-c]pyrazole-5-carboxylic acid | C14H11ClN2O2S | 571150-67-9 | Details |
| Indole-2,4,5,6,7-d5-3-acetic acid | C10H4D5NO2 | 76937-78-5 | Details |
| (+/-)-Propionylcarnitine chloride | C10H20ClNO4 | 18828-58-5 | Details |
| 2-(4-Bromophenyl)-2-methoxyacetic acid | C9H9BrO3 | 16053-90-0 | Details |
| 2-Amino-5-chlorobenzyl alcohol | C7H8ClNO | 37585-25-4 | Details |
| H-ATASRGASQAGAPQGC-NH2 | Details |
| 1-(4-Bromophenyl)-2-(pyridin-2-yl)ethan-1-amine | C13H13BrN2 | 1039865-46-7 | Details |
| 2-[(1,1-Dioxido-1,2-benzisothiazol-3-yl)amino]-3-methylbutanoic acid | C12H14N2O4S | 1396968-55-0 | Details |
| 3,5-Diiodo-4(4'-methoxyphenoxy)benzoic acid | C14H10I2O4 | 34043-77-1 | Details |
| 5-(chloromethyl)-1,3-dimethyl-1H-pyrazole hydrochloride | C6H10Cl2N2 | 1056598-95-8 | Details |
| 3-[(3-Bromophenoxy)methyl]-4-methoxybenzaldehyde | C15H13BrO3 | 438218-36-1 | Details |
| N-[4-Bromo-3-(trifluoromethyl)phenyl]-2-chloroacetamide | C9H6BrClF3NO | 40992-67-4 | Details |
| 1-((4-methylphenyl)sulfonyl)acetyl-4-cyclohexylthiosemicarbazide | C16H23N3O3S2 | 1023562-12-0 | Details |
| (H-Lys-Ile-Leu-Asn-Asp-Leu-Ser-Ser-Asp-Ala-Pro-Gly-Val-Pro-Arg)8-MAP | Details |
| 3-Bromo-1-(3-methylphenyl)piperidin-2-one | C12H14BrNO | 1342739-36-9 | Details |
| 2-(Methylamino)ethane-1-sulfonamide | C3H10N2O2S | 1186647-91-5 | Details |
| ethoxy-N-(2-formyl(3-thienyl))formamide | C8H9NO3S | 122805-79-2 | Details |
| 1-(2-Bromoethyl)cyclopropan-1-ol | C5H9BrO | 128312-82-3 | Details |
| 3-[(1-Ethyl-1H-1,3-benzodiazol-2-yl)amino]propan-1-ol | C12H17N3O | 631843-69-1 | Details |
| Ac-DEVD-6-Amino-D-Luciferin | Details |
| 5-(Methoxymethyl)-1,2-oxazole-3-carboxylic acid | C6H7NO4 | 95312-32-6 | Details |
| 3-(4-Methylphenyl)-1-[(4-methylphenyl)methyl]-1H-pyrazole-4-carboxylic acid | C19H18N2O2 | 956508-54-6 | Details |
| OR2K2 antibody | Details |
| HBsAg-adw, Recombinant | Details |
| tert-Butyl N-(2,2-dimethylpiperidin-4-yl)carbamate | C12H24N2O2 | 1785257-92-2 | Details |
| 1-Benzoyl-4-phenyl-1,2,3,6-tetrahydropyridine | C18H17NO | 1257268-45-3 | Details |
| 2-Methoxyisopropylcyanoacetate | C7H11NO3 | 32804-79-8 | Details |
| 3-Amino-3-(4-biphenylyl)propionic Acid | C15H15NO2 | 63974-15-2 | Details |
| 1,4-Dimethyl-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid | C7H8N2O3 | 2138515-47-4 | Details |
| PO5F1 antibody | Details |
| 2-(Cyclopropylmethoxy)ethane-1-sulfonamide | 1339855-69-4 | Details |
| LCBiot-VYATRSSAVRLRSSVP-OH | Details |
| Norsertraline-HRP | Details |
| Product Total： Product Page： | ||||
| 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 | ||||